In addition, third-ventricle injections of OXT improved glucose intolerance and fasting blood insulin levels in mice under chronic high-fat diet feeding and led to significant improvements in glucose tolerance, β-cell insulin secretion, and blood insulin levels in the multiple low-doses administration of STZ-induced autoimmune diabetes in mice (248). This evidence concerns the gene INS and Glucose intolerance.